Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Influence of Different Treatment Strategies on New‐Onset Atrial Fibrillation Among Patients With Primary Aldosteronism: A Nationwide Longitudinal Cohort‐Based Study
Chien‐Ting Pan, Che‐Wei Liao, Cheng‐Hsuan Tsai, et al.
Journal of the American Heart Association (2020) Vol. 9, Iss. 5
Open Access | Times Cited: 17

Showing 17 citing articles:

2022 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the Management of Hypertension.
Tzung‐Dau Wang, Chern‐En Chiang, Ting‐Hsing Chao, et al.
PubMed (2022) Vol. 38, Iss. 3, pp. 225-325
Closed Access | Times Cited: 90
The impact of sodium‐glucose co‐transporter‐2 inhibitors on dementia and cardiovascular events in diabetic patients with atrial fibrillation
Yun‐Yu Chen, Hao‐Chih Chang, Yenn‐Jiang Lin, et al.
Diabetes/Metabolism Research and Reviews (2024) Vol. 40, Iss. 2
Open Access | Times Cited: 11
The Effect of Aldosterone on Cardiorenal and Metabolic Systems
Hiromasa Otsuka, Masanori Abe, Hiroki Kobayashi
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5370-5370
Open Access | Times Cited: 22
Cerebro-Cardiovascular Risk, Target Organ Damage, and Treatment Outcomes in Primary Aldosteronism
Xiao Lin, Muhammad Hasnain Ehsan Ullah, Wu Xiong, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 8
Open Access | Times Cited: 26
Evolution of the cardiometabolic profile of primary hyperaldosteronism patients treated with adrenalectomy and with mineralocorticoid receptor antagonists: results from the SPAIN-ALDO Registry
Marta Araujo‐Castro, Miguel Paja, Marga González Boillos, et al.
Endocrine (2022) Vol. 76, Iss. 3, pp. 687-696
Closed Access | Times Cited: 24
Major Adverse Cardiovascular Events in Primary Aldosteronism After Adrenalectomy or Mineralocorticoid Receptor Antagonist Treatment: A Systematic Review and Meta‐Analysis
Chien‐Wei Huang, Tse‐Ying Huang, Yafei Yang, et al.
Journal of the American Heart Association (2025) Vol. 14, Iss. 3
Open Access
Therapeutic Outcomes with Surgical and Medical Management of Primary Aldosteronism
Heather Wachtel, Douglas L. Fraker
Current Cardiology Reports (2021) Vol. 23, Iss. 7
Open Access | Times Cited: 18
Time-Dependent Risk of Atrial Fibrillation in Patients With Primary Aldosteronism After Medical or Surgical Treatment Initiation
Kyoung Jin Kim, Namki Hong, Min Yu, et al.
Hypertension (2021) Vol. 77, Iss. 6, pp. 1964-1973
Open Access | Times Cited: 18
Treatment of primary aldosteronism: Clinical practice guidelines of the Taiwan Society of Aldosteronism
Chi‐Shin Tseng, Chieh‐Kai Chan, Hsiang‐Ying Lee, et al.
Journal of the Formosan Medical Association (2023) Vol. 123, pp. S125-S134
Open Access | Times Cited: 7
New-Onset Atrial Fibrillation in Patients With Primary Aldosteronism Receiving Different Treatment Strategies: Systematic Review and Pooled Analysis of Three Studies
Cheng‐Hsuan Tsai, Yali Chen, Chien‐Ting Pan, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 14
Associated factors and effects of comorbid atrial fibrillation in hypertensive patients due to primary aldosteronism
Shintaro Sakaguchi, Ryuji Okamoto, Chisa Inoue, et al.
Journal of Human Hypertension (2022) Vol. 37, Iss. 9, pp. 757-766
Closed Access | Times Cited: 3
Mineralocorticoid receptor antagonist treatment improved arterial stiffness in patients with primary aldosteronism: a cohort study compared with adrenalectomy
Che‐Wei Liao, Yen-Tin Lin, Cheng‐Hsuan Tsai, et al.
Therapeutic Advances in Chronic Disease (2023) Vol. 14
Open Access | Times Cited: 1
Targeted treatment reverses increased left cardiac work in unilateral versus bilateral primary aldosteronism
Eeva Kokko, Marianna Viukari, Jenni Koskela, et al.
American Journal of Hypertension (2024) Vol. 37, Iss. 11, pp. 884-892
Open Access
Suppressed Renin Status is a Risk Factor for Cardiocerebrovascular Events in Bilateral Primary Aldosteronism Treated with Mineralocorticoid Receptor Antagonists
Yiran Jiang, Lihua Zhou, Cui Zhang, et al.
Endocrine Practice (2024)
Open Access
Atrial Fibrillation and Primary Aldosteronism: A Meta-Analysis
Eva Muja, Ilirian Laçi, Sonil Marko, et al.
Cardiology Research and Cardiovascular Medicine (2023) Vol. 8, Iss. 1
Open Access
Reversal of arterial stiffness in medically and surgically treated unilateral primary aldosteronism
Zheng‐Wei Chen, Che‐Wei Liao, Chien‐Ting Pan, et al.
Journal of Hypertension (2023) Vol. 42, Iss. 3, pp. 538-545
Closed Access
Editorial: Diagnosis and Treatment of Primary Aldosteronism: from Clinical Origin to Translational Research
Wan-Chen Wu, Qiang Wei, Vin‐Cent Wu
Frontiers in Endocrinology (2021) Vol. 12
Open Access
Page 1

Scroll to top